?-Mangostin decreases ?-amyloid peptides production via modulation of amyloidogenic pathway.
Ontology highlight
ABSTRACT: AIMS:?-amyloid (A?) aggregation and deposition play a central role in the pathogenic process of Alzheimer's disease (AD). ?-Mangostin (?-M), a polyphenolic xanthone, have been shown to dissociate A? oligomers. In this study, we further investigated the effect of ?-M on A? production and its molecular mechanism. METHODS:The A? and soluble amyloid precursor protein ? (sAPP?) in culture medium of cortical neurons were measured by ELISA. The activities of ?-, ?-, and ?-secretases were assayed, and the interaction between ?-M and ?- or ?-secretases was simulated by molecular docking. RESULTS:?-M significantly decreased A?40 and A?42 production. ?-M did not affect the expression of enzymes involved in nonamyloidogenic and amyloidogenic pathways, but significantly decreased the activities of ?-secretase and likely ?-secretase with IC50 13.22 nmol·L-1 and 16.98 nmol·L-1 , respectively. Molecular docking demonstrated that ?-M interacted with ?-site amyloid precursor protein cleaving enzyme 1 and presenilin 1 to interfere with their active sites. CONCLUSIONS:Our data demonstrate that ?-M decreases A? production through inhibiting activities of ?-secretase and likely ?-secretase in the amyloidogenic pathway. The current data together with previous study indicated that ?-M could be a novel neuroprotective agent through intervention of multiple pathological processes of AD.
SUBMITTER: Zhao LX
PROVIDER: S-EPMC6492755 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA